Trial Information

Summary: Ariflo Study for Adults with COPD

Health Sciences Research Center is conducting a research study to evaluate the safety, efficacy and tolerability of Ariflo in patients with COPD (chronic bronchitis or emphysema).

You may participate in this study if you:

• are 40 years of age or older,
• have a clinical diagnosis of COPD,
• are a smoker or ex-smoker,
• have had at least one worsening of COPD which required oral steroids, antibiotics and/or hospitalization.

You cannot participate in this study if you:

• have poorly controlled COPD in the two months prior to Visit 1,
• require supplemental oxygen more than "as needed" use (less than 2 hours per day),
• have significant gastrointestinal, pancreatic or kidney disease,
• are unable to withhold the required respiratory medication prior to study visits.

Study Benefits

• Qualified participants will be compensated for time and travel.
• The information learned from this study may help others with COPD.
• All study visits, study medications an study-related exams are provided at no cost to you

If you would like to learn more about participating in this study, please send an e-mail message using the form below.